newsEU to support novel antibiotics with €20 million funding14 April 2021 | By Hannah Balfour (European Pharmaceutical Review)BioVersys will receive €20 million in funding to support its development of new treatments for antimicrobial resistant infections.
newsFDA approves Recarbrio for treatment of bacterial pneumonias5 June 2020 | By Hannah Balfour (European Pharmaceutical Review)Recarbrio (imipenem-cilastatin and relebactam) was approved for the treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP).